Search Results "#Inflammatory"

Blogs

arrow_forward View More Results
Inflammatory Bowel Disease Biologics Market Forecast to Hit USD 130.8 Billion by 2036; India Posts 10.1% CAGR, China 9.9%, Germany 7.9%
Posted by Adam aam on October 08 2026 at 02:18 PM   public
The inflammatory bowel disease biologics market is forecast to expand from USD 60.73 billion in 2026 to USD 130.81 billion by 2036, registering an 8.0% CAGR over the forecast period. Fact.MR attr...
Inflammatory Bowel Disease Treatment Market Size and CAGR Forecast 2026–2033
Posted by Rakesh Jogi on September 16 2026 at 02:05 PM   public
The global Inflammatory Bowel Disease Treatment Market is benefiting from rising disease prevalence, growing adoption of advanced biologics, expanding access to targeted therapies, increasing awa...
Idiopathic Inflammatory Myopathy Treatment Market Opportunities in Rare Disease Therapeutics
Posted by Rakesh Jogi on September 10 2026 at 01:52 PM   public
The global Idiopathic Inflammatory Myopathy Treatment Market is benefiting from rising disease awareness, improved diagnostic capabilities, growing patient identification, strong pipeline candida...
Inflammatory Bowel Disease (IBD) Treatment Market: How Are IL-23 Inhibitors Reshaping the Biologic Treatment Paradigm?
Posted by Surbhi on July 09 2026 at 06:02 PM   public
IL-23 inhibitors in IBD treatment — the selective biologics targeting the p19 subunit of interleukin-23 (risankizumab/Skyrizi, guselkumab/Tremfya, mirikizumab/Omvoh) demonstrating superior effica...
arrow_forward